HEALTH● LOWSep 22 · Sep 22, 2026, 11:26 AM
Merck says FDA approved label update for PAH therapy Winrevair
Seeking Alpha Tech · north america
Merck announced that the FDA has approved a label update for its pulmonary arterial hypertension therapy, Winrevair. This is important for the medical community and patients using this treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH16m agoPope Leo 'slept well' as his recovery continues, Vatican saysABC NewsHEALTH2h ago161 confirmed measles cases, one death reported in KozhikodeThe HinduHEALTH4h agoLongevity-first healthcare takes spotlight at Abu Dhabi Future Health SummitSouth China Morning PostHEALTH5h agoKenya’s Ebola cases test preparedness beyond NairobiAl Jazeera [en]